EUR 234.5
(0.51%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 25.39 Billion EUR | 3.68% |
2022 | 24.49 Billion EUR | 23.58% |
2021 | 19.82 Billion EUR | 37.36% |
2020 | 14.42 Billion EUR | -17.03% |
2019 | 17.39 Billion EUR | 60.53% |
2018 | 10.83 Billion EUR | 17.96% |
2017 | 9.18 Billion EUR | 29.08% |
2016 | 7.11 Billion EUR | 5.94% |
2015 | 6.71 Billion EUR | 18.45% |
2014 | 5.67 Billion EUR | 11.94% |
2013 | 5.06 Billion EUR | 1.52% |
2012 | 4.98 Billion EUR | 19.08% |
2011 | 4.18 Billion EUR | 7.66% |
2010 | 3.89 Billion EUR | 19.08% |
2009 | 3.26 Billion EUR | 6.3% |
2008 | 3.07 Billion EUR | 5.72% |
2007 | 2.9 Billion EUR | 8.11% |
2006 | 2.68 Billion EUR | 10.96% |
2005 | 2.42 Billion EUR | 7.25% |
2004 | 2.26 Billion EUR | 6.8% |
2003 | 2.11 Billion EUR | -1.02% |
2002 | 2.13 Billion EUR | 3.28% |
2001 | 2.07 Billion EUR | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q2 | 13.29 Billion EUR | 0.0% |
2023 Q2 | 12.85 Billion EUR | 0.0% |
2023 Q4 | 12.54 Billion EUR | 0.0% |
2023 FY | 25.39 Billion EUR | 3.68% |
2022 Q4 | 12.5 Billion EUR | 0.0% |
2022 FY | 24.49 Billion EUR | 23.58% |
2022 Q2 | 11.99 Billion EUR | 0.0% |
2021 Q2 | 8.76 Billion EUR | 0.0% |
2021 Q4 | 11.05 Billion EUR | 0.0% |
2021 FY | 19.82 Billion EUR | 37.36% |
2020 Q4 | 8.19 Billion EUR | 0.0% |
2020 Q2 | 6.23 Billion EUR | 0.0% |
2020 FY | 14.42 Billion EUR | -17.03% |
2019 Q4 | 8.61 Billion EUR | 0.0% |
2019 Q2 | 8.77 Billion EUR | 0.0% |
2019 FY | 17.39 Billion EUR | 60.53% |
2018 Q4 | 6.26 Billion EUR | 0.0% |
2018 FY | 10.83 Billion EUR | 17.96% |
2018 Q2 | 4.56 Billion EUR | 0.0% |
2017 FY | 9.18 Billion EUR | 29.08% |
2017 Q2 | 3.85 Billion EUR | 0.0% |
2017 Q4 | 5.32 Billion EUR | 0.0% |
2016 FY | 7.11 Billion EUR | 5.94% |
2016 Q2 | 3.58 Billion EUR | 0.0% |
2016 Q4 | 3.53 Billion EUR | 0.0% |
2015 Q2 | 3.4 Billion EUR | 0.0% |
2015 FY | 6.71 Billion EUR | 18.45% |
2015 Q4 | 3.3 Billion EUR | 0.0% |
2014 Q2 | 2.78 Billion EUR | 0.0% |
2014 FY | 5.67 Billion EUR | 11.94% |
2014 Q4 | 2.89 Billion EUR | 0.0% |
2013 Q2 | 2.57 Billion EUR | 0.0% |
2013 FY | 5.06 Billion EUR | 1.52% |
2013 Q4 | 2.48 Billion EUR | 0.0% |
2012 Q4 | 1.24 Billion EUR | 0.0% |
2012 Q2 | 1.24 Billion EUR | 0.0% |
2012 Q1 | 1.24 Billion EUR | 19.08% |
2012 FY | 4.98 Billion EUR | 19.08% |
2012 Q3 | 1.24 Billion EUR | 0.0% |
2011 Q2 | 1.04 Billion EUR | 0.0% |
2011 Q3 | 1.04 Billion EUR | 0.0% |
2011 Q4 | 1.04 Billion EUR | 0.0% |
2011 FY | 4.18 Billion EUR | 7.66% |
2011 Q1 | 1.04 Billion EUR | 7.66% |
2010 Q3 | 972.88 Million EUR | 0.0% |
2010 FY | 3.89 Billion EUR | 19.08% |
2010 Q4 | 972.88 Million EUR | 0.0% |
2010 Q2 | 972.88 Million EUR | 0.0% |
2010 Q1 | 972.88 Million EUR | 19.08% |
2009 Q1 | 816.99 Million EUR | 6.3% |
2009 Q2 | 816.99 Million EUR | 0.0% |
2009 Q3 | 816.99 Million EUR | 0.0% |
2009 Q4 | 816.99 Million EUR | 0.0% |
2009 FY | 3.26 Billion EUR | 6.3% |
2008 Q3 | 768.6 Million EUR | 0.0% |
2008 Q2 | 768.6 Million EUR | 0.0% |
2008 Q1 | 768.6 Million EUR | 5.72% |
2008 FY | 3.07 Billion EUR | 5.72% |
2008 Q4 | 768.6 Million EUR | 0.0% |
2007 FY | 2.9 Billion EUR | 8.11% |
2007 Q4 | 727.02 Million EUR | 0.0% |
2007 Q3 | 727.02 Million EUR | 0.0% |
2007 Q2 | 727.02 Million EUR | 0.0% |
2007 Q1 | 727.02 Million EUR | 8.11% |
2006 Q1 | 672.48 Million EUR | 10.96% |
2006 Q4 | 672.48 Million EUR | 0.0% |
2006 Q3 | 672.48 Million EUR | 0.0% |
2006 Q2 | 672.48 Million EUR | 0.0% |
2006 FY | 2.68 Billion EUR | 10.96% |
2005 Q4 | 606.08 Million EUR | 0.0% |
2005 Q2 | 606.08 Million EUR | 0.0% |
2005 FY | 2.42 Billion EUR | 7.25% |
2005 Q1 | 606.08 Million EUR | 7.25% |
2005 Q3 | 606.08 Million EUR | 0.0% |
2004 FY | 2.26 Billion EUR | 6.8% |
2004 Q3 | 565.09 Million EUR | 0.0% |
2004 Q1 | 565.09 Million EUR | 6.8% |
2004 Q2 | 565.09 Million EUR | 0.0% |
2004 Q4 | 565.09 Million EUR | 0.0% |
2003 Q1 | 529.1 Million EUR | -1.02% |
2003 Q4 | 529.1 Million EUR | 0.0% |
2003 FY | 2.11 Billion EUR | -1.02% |
2003 Q3 | 529.1 Million EUR | 0.0% |
2003 Q2 | 529.1 Million EUR | 0.0% |
2002 Q3 | 534.56 Million EUR | 0.0% |
2002 FY | 2.13 Billion EUR | 3.28% |
2002 Q2 | 534.56 Million EUR | 0.0% |
2002 Q1 | 534.56 Million EUR | 3.28% |
2002 Q4 | 534.56 Million EUR | 0.0% |
2001 FY | 2.07 Billion EUR | 0.0% |
2001 Q3 | 517.59 Million EUR | 0.0% |
2001 Q2 | 517.59 Million EUR | 0.0% |
2001 Q1 | 517.59 Million EUR | 0.0% |
2001 Q4 | 517.59 Million EUR | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
Crossject Société Anonyme | 145 Thousand EUR | -17513693.103% |
Safe Orthopaedics SA | 5.86 Million EUR | -433187.835% |
Spineway SA | 10.51 Million EUR | -241320.287% |
Amplitude Surgical SA | 106.01 Million EUR | -23853.254% |
Sartorius Stedim Biotech S.A. | 2.77 Billion EUR | -814.97% |
bonyf N.V. | 309.37 Thousand EUR | -8208411.381% |